James Hardie Industries Plc - Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by James Hardie Industries Plc on February 5, 2019, for the month of February 2019. The filing serves as a cover document for the company's Third Quarter (Q3) results for the fiscal year ending June 30, 2019 (FY19). The reporting period covered by the attached exhibits is the quarter ended December 31, 2018.
Key Financial Metrics
The provided text is a cover sheet and index; it does not contain specific financial data. The actual revenue, profit, cash flow, margins, debt, and liquidity figures are located in the attached exhibits (specifically Exhibit 99.2, 99.3, and 99.5) which are not included in the input text. Therefore, no specific financial values can be reported from this document alone.
Material Changes
The filing text does not provide specific details on material changes versus the prior comparable period. It references a "Management's Analysis of Results" (Exhibit 99.3) and "Condensed Consolidated Financial Statements" (Exhibit 99.5) where such comparisons would be detailed.
Guidance, Outlook, and Risks
The document contains an extensive "Forward-Looking Statements" section outlining significant risks and uncertainties that could affect future performance. Key areas of risk include:
- Asbestos Liabilities: Risks related to prior asbestos manufacturing, including contributions to the Asbestos Injury Compensation Fund (AICF), potential shortfalls, and currency exchange impacts on recorded liabilities.
- Legal and Regulatory: Exposure to product liability, environmental, and consumer class action proceedings, as well as changes in tax laws.
- Market Conditions: Dependence on US and Asia Pacific housing markets, new home construction levels, consumer confidence, and interest rates.
- Operational Risks: Costs associated with plant closures or capital projects, raw material supply and costs, and the integration of the Fermacell acquisition.
- Financial Risks: Ability to renew credit facilities, currency exchange risks, and reliance on a concentrated customer base.
The company explicitly states it assumes no obligation to update forward-looking statements except as required by law.
Investor Verification Checklist
- Review Exhibit 99.2 (Media Release) and Exhibit 99.5 (Financial Statements) for actual Q3 FY19 revenue, earnings, and cash flow figures.
- Verify the specific amount of contributions made to the Asbestos Injury Compensation Fund (AICF) for the quarter.
- Check the "Management's Analysis of Results" (Exhibit 99.3) for explanations of any variances in operating margins or segment performance.
- Confirm the status of the Fermacell integration and any associated costs or synergies realized in the quarter.
- Assess the impact of currency exchange rates on the reported results, given the company's international operations.